Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000528716 | SCV000628767 | likely benign | Neurofibromatosis, type 1 | 2024-09-18 | criteria provided, single submitter | clinical testing | |
Center for Human Genetics, |
RCV000528716 | SCV000782103 | uncertain significance | Neurofibromatosis, type 1 | 2016-11-01 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002420367 | SCV001188548 | likely benign | Hereditary cancer-predisposing syndrome; Cardiovascular phenotype | 2018-03-10 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Sema4, |
RCV001026211 | SCV002528091 | likely benign | Hereditary cancer-predisposing syndrome | 2021-04-14 | criteria provided, single submitter | curation |